Joel Gore to Hemorrhage
This is a "connection" page, showing publications Joel Gore has written about Hemorrhage.
Connection Strength
1.292
-
Ogunsua AA, Touray S, Lui JK, Ip T, Escobar JV, Gore J. Body mass index predicts major bleeding risks in patients on warfarin. J Thromb Thrombolysis. 2015 Nov; 40(4):494-8.
Score: 0.442
-
Fraielli K, Patel D, Wang D, Sargent K, Gore J. Successful use of fondaparinux in the setting of heparin-induced thrombocytopenia with thrombosis confirmed by serotonin-release assay and Factor V Leiden. J Clin Pharm Ther. 2019 Oct; 44(5):809-812.
Score: 0.142
-
Chamoun N, Mac?as CG, Donovan JL, Klugman R, Gore J, Salameh P, Tran MT. Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge. J Thromb Thrombolysis. 2017 May; 43(4):454-462.
Score: 0.123
-
Fox KA, Carruthers K, Steg PG, Avezum A, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KA. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. Eur Heart J. 2010 Mar; 31(6):667-75.
Score: 0.073
-
Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost. 2009 May; 101(5):878-85.
Score: 0.070
-
Gore JM, Spencer FA, Gurfinkel EP, L?pez-Send?n J, Steg PG, Granger CB, FitzGerald G, Agnelli G. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009 Jan 15; 103(2):175-80.
Score: 0.068
-
Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KA. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007 Dec 11; 116(24):2793-801.
Score: 0.064
-
Dauerman HL, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol. 2005 Nov 15; 96(10):1379-83.
Score: 0.055
-
Wang W, Lessard D, Kiefe CI, Goldberg RJ, Parish D, Helm R, Trymbulak K, Mehawej J, Abu H, Bamgbade BA, Hayward R, Gore J, Gurwitz JH, McManus DD, Saczynski JS. Differential effect of anticoagulation according to cognitive function and frailty in older patients with atrial fibrillation. J Am Geriatr Soc. 2023 02; 71(2):394-403.
Score: 0.045
-
Wang W, Saczynski JS, Lessard D, Goldberg RJ, Parish D, Helm R, Kiefe CI, Trymbulak K, Mehawej J, Abu H, Hayward R, Gore J, Gurwitz JH, McManus DD. Presence of Geriatric Conditions Is Prognostic of Major Bleeding in Older Patients with Atrial Fibrillation: a Cohort Study. J Gen Intern Med. 2022 11; 37(15):3893-3899.
Score: 0.043
-
Alonso A, Gore JM, Awad HH, Quill AL, Montalescot G, van de Werf F, Gulba DC, Fox KA, Eagle KA, Granger CB, Wyman A, Steg PG. Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry. Eur Heart J Acute Cardiovasc Care. 2013 Sep; 2(3):280-91.
Score: 0.024
-
Lalama J, Lewis PM, Gore J, Tran MT, Donovan J. How one academic medical center has managed potency changes with unfractionated heparin. J Thromb Thrombolysis. 2013 Jul; 36(1):91-5.
Score: 0.023
-
Awad HH, Zubaid M, Alsheikh-Ali AA, Al Suwaidi J, Anderson FA, Gore JM, Goldberg RJ. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. Am J Cardiol. 2011 Nov 01; 108(9):1252-8.
Score: 0.021
-
Sibbald M, Yan AT, Huang W, Fox KA, Gore JM, Steg PG, Eagle KA, Brieger D, Montalescot G, Goodman SG. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2010 Nov; 160(5):855-61.
Score: 0.020
-
Spencer FA, Goldberg RJ, Lessard D, Reed G, Emery C, Gore JM, Pacifico L, Weitz JI. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes. 2010 Jul; 3(4):390-4.
Score: 0.019
-
L?pez-Send?n J, Dabbous OH, L?pez de S? E, Stiles M, Gore JM, Brieger D, van de Werf F, Budaj A, Gurfinkel EP, Fox KA. In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events. Rev Esp Cardiol. 2009 May; 62(5):501-9.
Score: 0.018
-
Spencer FA, Gore JM, Lessard D, Emery C, Pacifico L, Reed G, Gurwitz JH, Goldberg RJ. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008 Nov; 100(5):780-8.
Score: 0.017
-
Budaj A, Flasinska K, Gore JM, Anderson FA, Dabbous OH, Spencer FA, Goldberg RJ, Fox KA. Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events. Circulation. 2005 Jun 21; 111(24):3242-7.
Score: 0.013
-
Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum A, Spencer F, Kline-Rogers E, Allegrone J, Pieper K, Fox KA, Eagle KA. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2004 Feb; 147(2):253-9.
Score: 0.012